SectorPharmaceutical
Established Date23/08/2021
Listing Date16/06/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees1032
Fiscal Year Ends31/12
Security TypeCommon stock
Office address9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg
Business
IntroductionAlvotech was incorporated on 23 August 2021 under the laws of the Grand Duchy of Luxembourg. The company is a biotechnology company founded by Robert Wessman focused on developing and manufacturing biosimilars for patients worldwide. The company seeks to become a global leader in biosimilars through a fully integrated approach and extensive in-house capabilities by providing high-quality, cost-effective products and services. The company's current pipeline contains eight biosimilar drug candidates designed to treat autoimmune diseases, eye diseases, osteoporosis, respiratory diseases and cancer.